Annual CFF
$16.39 M
+$14.66 M+848.21%
December 1, 2023
Summary
- As of February 21, 2025, MAZE annual cash flow from financing activities is $16.39 million, with the most recent change of +$14.66 million (+848.21%) on December 1, 2023.
- During the last 3 years, MAZE annual CFF has risen by +$14.66 million (+848.21%).
Performance
MAZE Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFF
$22.59 M
NaN%
September 1, 2024
Summary
- As of February 21, 2025, MAZE quarterly cash flow from financing activities is $22.59 million
Performance
MAZE Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFF
$22.59 M
NaN%
September 1, 2024
Summary
- As of February 21, 2025, MAZE TTM cash flow from financing activities is $22.59 million
Performance
MAZE TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
MAZE Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +848.2% | - | - |
| 3 y3 years | +848.2% | - | - |
| 5 y5 years | +848.2% | - | - |
MAZE Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | -89.5% | at high | -99.1% | at high | -99.1% |
| 5 y | 5-year | at high | -89.5% | at high | -99.1% | at high | -99.1% |
| alltime | all time | at high | -89.5% | at high | -99.1% | at high | -99.1% |
Maze Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $22.59 M(>+9900.0%) | $22.59 M(>+9900.0%) |
| Dec 2023 | $16.39 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | $197.00 K | $197.00 K |
| Dec 2022 | $1.73 M | - | - |
FAQ
- What is Maze Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Maze Therapeutics?
- What is Maze Therapeutics annual CFF year-on-year change?
- What is Maze Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Maze Therapeutics?
- What is Maze Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Maze Therapeutics?
What is Maze Therapeutics annual cash flow from financing activities?
The current annual CFF of MAZE is $16.39 M
What is the all time high annual CFF for Maze Therapeutics?
Maze Therapeutics all-time high annual cash flow from financing activities is $16.39 M
What is Maze Therapeutics annual CFF year-on-year change?
Over the past year, MAZE annual cash flow from financing activities has changed by +$14.66 M (+848.21%)
What is Maze Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of MAZE is $22.59 M
What is the all time high quarterly CFF for Maze Therapeutics?
Maze Therapeutics all-time high quarterly cash flow from financing activities is $22.59 M
What is Maze Therapeutics TTM cash flow from financing activities?
The current TTM CFF of MAZE is $22.59 M
What is the all time high TTM CFF for Maze Therapeutics?
Maze Therapeutics all-time high TTM cash flow from financing activities is $22.59 M